Skip to main content
Caplight Logo









Inteligex Inc.

Inteligex Inc.

Private
Toronto, OntarioHealthcare & Life Scienceshttps://inteligexinc.com/

Last Round

Grant

Dec 10, 2025

Total Funding Raised

$105,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Inteligex Inc. is a regenerative medicine company developing proprietary stem cell-based therapeutics to restore function in individuals with spinal cord injury and other diseases of the Central Nervous System.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Clinical Trials, Healthcare Analytics

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

stem cell therapyspinal cord injurySCIregenerative medicineneural stem cellscell therapybioengineered stem cellscentral nervous systemCNSclinical-stage biotechpersonalized medicinedisease progression predictionmedical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inteligex Inc. Comparables

Compare Inteligex Inc. with similar companies based on industry and business-model similarity.

Inteligex Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuroplast
79%
NurExone Biologic Inc.
78%
Matricelf
77%

Inteligex Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 10, 2025
AcceleratorJan 21, 2025

Inteligex Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 10, 2025

    Received grant from Give Back Health Innovation Foundation.

  • Jan 21, 2025

    $105K raised from Federal Economic Development Agency and Ontario Genomics.

Inteligex Inc. Filings

Explore SEC and related filing metadata, where available.

Inteligex Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Inteligex Inc.'s valuation, stock price, and market status.

Is Inteligex Inc. a public or private company?

Inteligex Inc. is a private company.

What is the current stock price of Inteligex Inc.?

Inteligex Inc. is a private company, so its shares have no public market price. Caplight tracks Inteligex Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Inteligex Inc. worth (valuation)?

Valuation information for Inteligex Inc. is not publicly available.

Can I buy Inteligex Inc. stock?

Inteligex Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Inteligex Inc.'s last funding round?

Inteligex Inc.'s most recent funding round was Grant on December 10, 2025.

Who are the main investors in Inteligex Inc.?

Key investors in Inteligex Inc. include Give Back Health Innovation Foundation.

Will Inteligex Inc. IPO soon?

No public IPO plans have been announced for Inteligex Inc..

How can I track Inteligex Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Inteligex Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersToronto, Ontario
Year Founded2018
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?